Latest round

Series B

Last raised

Aug 2025

Total raised

$37M

Investors

4

About Caremo

, Ltd operates as a biotenology company that committed to providing drug discovery full life cycle services for biotechnology and pharmaceutical enterprises. As of August 2023, it has more than 400 employees. It has R&D lab with11,000 square meters, and equipped with over 500 devices. It has three branches in Nanjing. The company's business can be categorized into drug screening, cell biology, pharmacology and efficacy, drug metabolism, non-clinical safety evaluation, formulation technology, clinical research, customizable development and new drug investment. The company generates revenue by researching and providing its own drug products. The company will develop its business and build its R&D platform.

Who invested in Caremo

4 investors across 3 rounds

See all investors in Caremo

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 26, 2025

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Apr 28, 2023

    Amount

    $14M

    Investors

    Locked

  3. Series A

    Jun 18, 2022

    Amount

    $22M

    Investors

    Locked

Questions about Caremo

Who invested in Caremo?

Caremo has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Caremo raised?

Caremo has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Caremo last raise money?

Caremo's most recent round on record is a Series B, in Aug 2025.

What does Caremo do?

, Ltd operates as a biotenology company that committed to providing drug discovery full life cycle services for biotechnology and pharmaceutical enterprises.

Where is Caremo headquartered?

Caremo is headquartered in Nanjing, China.

Which VCs invest in companies like Caremo?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Caremo's stage. Their profiles are linked below.

Raising like Caremo? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.